Series A funding round for Neurana Pharmaceuticals raising $60M in May 2018
Series A funding round for Neurana Pharmaceuticals raising $60M in May 2018
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$60M
Top Valuation
-
Neurana Pharmaceuticals raised $60M in a Series A round.
The round was announced on 05/01/18.
The round was led by David Kabakoff.